Table 1

Clinical characteristics of study subjects

 Diabetes duration (years)
0–1010–20>20
Type 1 (n=197)Type 2 (n=211)p ValueType 1 (n=190)Type 2 (n=151)p ValueType 1 (n=373)Type 2 (n=165)p Value
Current age (years)33.9 (7.7)39.5 (6.3)<0.000541.6 (6.9)48.4 (6.4)<0.000557.8 (10.7)61.4 (8.3)<0.0005
Age of diagnosis (years)27.5 (7.3)32.6 (5.5)<0.000525.9 (6.5)32.7 (5.3)<0.000524.9 (6.8)32.3 (6.8)<0.0005
DM duration (years)5.2 (2.6)5.6 (2.4)NS14.4 (2.8)14.2 (2.9)NS31.4 (8.4)27.6 (7.4)<0.0005
Systolic BP (mm Hg)127.4 (16.9)133.3 (19.5)0.001130.4 (17.1)138.1 (19.1)<0.0005138.8 (17.5)141.2 (20.6)NS
Diastolic BP (mm Hg)75.0 (12.4)79.8 (10.8)<0.000577.2 (9.8)76.8 (11.8)NS73.7 (9.8)71.3 (8.7)0.005
BMI (kg/m2)26.6 (5.0)34.7 (8.6)<0.000527.6 (4.8)34.9 (7.1)<0.000527.6 (4.7)33.4 (6.9)<0.0005
HbA1c (%)
(mmol/mol)
8.7 (1.9)
72 (21)
8.8 (2.0)
74 (22)
NS8.9 (1.8)
74 (18)
9.2 (2.0)
77 (21)
NS8.6 (1.3)
70 (14)
8.9 (1.7)
74 (18)
NS
Creatinine (µmol/L)77.3 (55.6)73.0 (20.1)NS80.6 (26.9)80.7 (48.7)NS94.7 (69.1)103.8 (60.9)NS
Total cholesterol (mmol/L)4.8 (1.1)4.7 (1.5)0.0024.7 (1.0)4.4 (1.4)<0.00054.4 (0.9)4.1 (0.9)<0.0005
HDL (mmol/L)1.7 (0.4)1.0 (0.3)<0.00051.5 (0.5)1.0 (0.3)<0.00051.6 (0.5)1.2 (0.3)<0.0005
Triglyceride (mmol/L)1.7 (4.3)2.8 (3.3)<0.00051.3 (0.9)2.7 (3.4)<0.00051.1 (0.9)2.0 (1.3)<0.0005
BMI>25 kg/m2 (%)57.490.5<0.000570.096.0<0.000570.090.9<0.0005
Hypertension (%)26.955.9<0.000543.278.1<0.000571.087.3<0.0005
Dyslipidemia (%)36.580.6<0.000531.182.1<0.000523.371.5<0.0005
Risk factors >2 (%)37.682.5<0.000546.890.7<0.000558.492.1<0.0005
Antihypertensive (%)10.638.3<0.000528.667.1<0.000557.775.9<0.0005
Statin (%)24.559.0<0.000548.173.5<0.000576.673.1NS
  • BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; NS, not significant.